When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on
In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible.
Together we define white space, push boundaries and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma.
ML Bio Solutions (ML Bio), an affiliate within BridgeBio Pharma, was founded in 2018, dedicated to finding a cure for limb-girdle muscular dystrophy type 2I/R9 FKRP-related (LGMD2I/LGMDR9). ML Bio is developing BBP-418, potentially the first oral treatment for patients with LGMD2I.
The VP, ML Bio Solutions Lead, Medical Affairs, is responsible for leading medical affairs teams for ML Bio Solutions, a Bridge Bio company, developing an enzyme substrate therapy for Limb Girdle Muscular Dystrophy Type R9, FKRP-related. This includes developing and executing medical strategies and plans, managing relationships with key stakeholders, and ensuring that medical activities and communications comply with applicable laws and regulations. The ideal candidate will have a solid clinical background, a deep understanding of the pharmaceutical industry, and a proven track record of success in leading and managing teams within matrixed environments -- such as with clinical development, regulatory, market access, and commercial -- to generate momentum to further the business in support of patients.
This is a field-based position.
We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.
Financial Benefits:
Health & Wellbeing:
Skill Development & Career Paths:
BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 20+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with two approved drugs. Our focus on scientific excellence and rapid execution aim to translate today’s discoveries into tomorrow’s medicines. We have U.S. offices in San Francisco, Palo Alto, and Raleigh, with small satellites in other parts of the country. We also have international offices in Montreal, Canada, and Zurich, Switzerland, and are expanding across Europe. To learn more about our story and company culture, visit us at https://bridgebio.com
Please mention you found this job on AI Jobs. It helps us get more startups to hire on our site. Thanks and good luck!
Be the first to apply. Receive an email whenever similar jobs are posted.